In gynecology, Ir-192 is primarily used in the treatment of cervical cancer and endometrial cancer. It is a key component of brachytherapy, where a radioactive source is placed close to or within the tumor. This allows for a high dose of radiation to be delivered directly to the cancerous cells while minimizing exposure to the surrounding healthy tissue.
